Imatinib GIST keeps finding new indications: successful treatment of dermatofibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor. Editorial Article uri icon

Overview

publication date

  • September 1, 2002

Research

keywords

  • Antineoplastic Agents
  • Dermatofibrosarcoma
  • Piperazines
  • Pyrimidines
  • Receptors, Platelet-Derived Growth Factor
  • Skin Neoplasms

Identity

Scopus Document Identifier

  • 0036731703

Digital Object Identifier (DOI)

  • 10.1200/JCO.2002.20.17.3568

PubMed ID

  • 12202652

Additional Document Info

volume

  • 20

issue

  • 17